Atlas Venture Life Science Advisors, LLC
Multi-stage venture firm, based in Cambridge, Massachusetts, reporting $2.6B of fund assets on its funds' Form ADV filings.
Composed from this organization's classification, location and filed figures.
2 additional team members, 14 additional co-investors and affiliates, 4 additional investments, funds and LPs, 10 events, 2 verified contacts (1 firm phone, 1 professional url)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 2 dealswith Flybridge Capital Partners
Invests most often alongside Flybridge Capital Partners (2 shared deals).
pair last observed on record 7 Feb 2013, not a deal date · The firms it syndicates with are the likeliest to see the same deals and to fill out its rounds.
Measuredshared rounds and portfolio companies on recordFor Founders building a round, co-investorsCo-investors →
People to know
View all people- MemberWhy: Named with investment responsibilityNo route on file yet
- MemberWhy: Named with investment responsibilityNo route on file yet
- MemberWhy: Named with investment responsibilityNo route on file yet
Relationship network
28 connected entities1 observed roundrounds 2016
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Fund or vehicle
- Person
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Atlas Venture Life Science Advisors, LLC: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Atlas Venture Life Science Advisors, LLC
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
9 companies on record, 2 new in 12 months
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Gemini Therapeutics, Inc. | Form D equity offering | unknown · board | Jason Paul Rhodes (strongly supported) | $2.0M form d sold | unknown | May 2, 2016 | Inference Form D |
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Team
86 current, 11 departed
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
- Member · 1 deal attributed
- Member
- Member
3 departed (kept with end dates)
- David Grayzel · Member · Nov 1, 2014 to Mar 31, 2026 Fact
- Jean-Francois Bernard Formela · Member · Nov 1, 2014 to Mar 31, 2026 Fact
- Peter Barrett · Member · Nov 1, 2014 to Mar 30, 2018 Inference
1 firm phone, 1 professional url on record, each with its source. Values open with the complete profile.
Funds and LPs
7 vehicles, 0 LPs disclosed
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Atlas Venture Opportunity Fund Ill, L.P. | Opportunity fund | 2025 form d first sale | Newly closed | $399M Mar 31, 2026 | 83 | $400M of $400M | Sep 4, 2025 |
| Atlas Venture Fund Xiii, L.P. | Fund | 2022 form d first sale | Active deployment | $551M Mar 31, 2026 | 87 | $450M of $450M | Mar 3, 2022 |
| Atlas Venture Opportunity Fund II, L.P. | Opportunity fund | 2021 form d first sale | Mature | $287M Mar 31, 2026 | 70 | $300M of $300M | Oct 1, 2021 |
| Allocator | Type | Fund | Amount | Date | Source |
|---|---|---|---|---|---|
| The Grantham Foundation for the Protection of the Environment | FOUNDATION | Atlas Venture Fund Xiii, L.P. | $1.7M fair value on the foundation's return | reported as of Dec 31, 2024 | Fact IRS Form 990 / 990-PF e-file returns |
| The Grantham Foundation for the Protection of the Environment | FOUNDATION | Atlas Venture Fund X, L.P. | $4.6M fair value on the foundation's return | reported as of Dec 31, 2024 | Fact IRS Form 990 / 990-PF e-file returns |
Relationships across DFX
17 co-investors · on 2 other DFX graphs
- 2013-02-072 shared deals · recurring
- 2026-09-161 shared deal · one time
- 2026-09-161 shared deal · one time
Across DFX and the capital chainon 2 other DFX graphs · 1 capital path ShowHide
- The same institution is held on Allocators, RIA and Wealth, matched by identifier. See which records
Atlas Venture Life Science Advisors, LLC is the same institution as 2 records in Allocators and RIA and Wealth.
DFX found 2 relationships across 2 datasets
Which record it is in each graph, what it is called there, and how the two were matched.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Checking your plan…
Atlas Venture Life Science Advisors, LLC sits on 1 traced path of capital across the graphs.
DFX traced 1 path of capital through this record
Every record on each path, what it committed or lent, and as of when.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Derived from allocator disclosures, BDC schedules and SEC filings; confidence is the weakest hop.
Checking your plan…
Evidence and history
15 dated events, 53 observations from 2 sources
- Mar 31, 2026Atlas Venture Fund Xiv, L.P. first reported on Form ADV by Atlas Venture Life Science Advisors, LLC (Venture Capital Fund), GAV $452,031,000
- Mar 31, 2026Atlas Venture Opportunity Fund III, L.P. first reported on Form ADV by Atlas Venture Life Science Advisors, LLC (Venture Capital Fund), GAV $399,029,000
- Mar 31, 2026David Grayzel (Member) no longer on Schedule A of Atlas Venture Life Science Advisors, LLC
- Mar 31, 2026Jean-Francois Bernard Formela (Member) no longer on Schedule A of Atlas Venture Life Science Advisors, LLC
- Mar 31, 2023Atlas Venture Fund Xiii, L.P. first reported on Form ADV by Atlas Venture Life Science Advisors, LLC (Venture Capital Fund), GAV $444,700,000
Address, phone, Form ADV filing and ownersForm ADV filed Mar 31, 2026 · 8 private fundsShowHide
- Headquarters
- Cambridge, MAadviserinfo.sec.gov
- Office address
- unknownadviserinfo.sec.gov
- Business phone
- unknownadviserinfo.sec.gov
- Website
- ATLASVENTURE.COM
- SEC adviser type
- Exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- Venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 8 (8 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $3.0Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Classification history
Every classification this record has carried2 on recordShowHide
- Sep 23, 2026Multi-stage venture firm (confirmed, 95%)Both early and growth/opportunity families, reported GAV $2.6B
- Sep 12, 2026Multi-stage venture firm (confirmed, 95%)Both early and growth/opportunity families, reported GAV $2.4B
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | VC exemption, VC funds reported | Mar 31, 2026 | Fact | Form ADV |
| SEC exemption claimed | Venture capital fund adviser | Mar 31, 2026 | Fact | Form ADV |
| SEC exemption claimed | Venture capital fund adviser | Mar 29, 2024 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 31, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 31, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 29, 2024 | Fact | Form ADV |
| First Form ADV filing | 2015-02-19 | Mar 31, 2026 | Fact | Form ADV |
| First Form ADV filing | 2015-02-19 | Mar 29, 2024 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-29 | Sep 30, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-25 | Sep 26, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-23 | Sep 24, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-21 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-22 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-31 | Mar 31, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-31 | Mar 31, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2024-03-29 | Mar 29, 2024 | Fact | Form ADV |
| SEC status | ERA - Active | Mar 31, 2026 | Fact | Form ADV |
| SEC status effective | 2015-02-19 | Mar 31, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 31, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 29, 2024 | Fact | Form ADV |
| Business phone | Mar 31, 2026 | Fact | Form ADV | |
| Business phone | Mar 29, 2024 | Fact | Form ADV | |
| Headquarters | Cambridge, MA | Mar 31, 2026 | Fact | Form ADV |
| Headquarters | Cambridge, MA | Mar 29, 2024 | Fact | Form ADV |
| Office address | Mar 31, 2026 | Fact | Form ADV | |
| Office address | Mar 29, 2024 | Fact | Form ADV | |
| Legal form | Limited Liability Company | Mar 31, 2026 | Fact | Form ADV |
| Legal form | Limited Liability Company | Mar 29, 2024 | Fact | Form ADV |
| Private funds reported | 8 | Mar 31, 2026 | Fact | Form ADV |
| Private funds reported | 8 | Mar 31, 2026 | Fact | Form ADV |
| Private funds reported | 6 | Mar 29, 2024 | Fact | Form ADV |
| Private fund gross assets (reported) | $3.0B | Mar 31, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $3.0B | Mar 31, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $2.4B | Mar 29, 2024 | Fact | Form ADV |
| Schedule a diff | sadiff-1 | Mar 31, 2026 | Fact | Form ADV |
| Venture funds reported | 8 | Mar 31, 2026 | Fact | Form ADV |
| Venture funds reported | 8 | Mar 31, 2026 | Fact | Form ADV |
| Venture funds reported | 6 | Mar 29, 2024 | Fact | Form ADV |
| Website | Mar 31, 2026 | Fact | Form ADV | |
| Website | Mar 29, 2024 | Fact | Form ADV |
How this is scored
Scores, classification basis and filing advisersMulti-stage venture firm, confirmed · 2 filing advisers share this firmShowHide
Both early and growth/opportunity families, reported GAV $2.6B
One of 2 advisers that share atlasventure.com; the firm is Atlas Venture. Atlas Venture. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
- importance
- gav: $1 · funds: 0.58 · people: 0.16 · investments: 0 · co investors: 0
- active deployment
- investments 12m: 0 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 1 · latest investment at: not scored
- emerging manager
- fund count: 7 · reported gav: $2.6B · first adv filing: 2015-02-19 · years since first filing: 11.6
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Record history
- Grouped with firm2026-09-12
- Adviser's first ADV filing2015-02-19source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.